Using % predicted change during bronchial challenge testing to remove bias

Dean,J.,Singh,D.

DOI: https://doi.org/10.1183/13993003.congress-2024.oa4588

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:The methacholine challenge assesses bronchial hyper-reactivity, reporting the provocative dose causing a 20% fall in FEV 1 (PD 20 ). Patients with low baseline values require a smaller volume fall compared to those with higher baseline values, introducing bias. Change in % predicted has been advocated for reversibility testing to remove this bias, but this has not been employed in bronchial challenge testing. Aim: To evaluate % predicted decrease during bronchial challenge. Data from 15 asthma patients was assessed. Methacholine challenge was performed as per ERS 2017 guidelines, utilising a 20 second protocol with a jet nebuliser (AeroEclipse BAN II). Change in % predicted was calculated at each dose as ((FEV 1meth -FEV 1pre )*100)/FEV 1pred . PD values based on fall in % predicted were compared to PD 20 using Wilcoxon test, with p < 0.05 considered significant. The fall in % predicted that equated to a 20% fall from baseline (figure 1) ranged from 14.7% to 22.2%. A PD value using a 15% fall in predicted was significantly lower than PD 20 (median: 14μg vs 21μg, p = 0.0002), and would have resulted in 3 patients requiring one less dose of methacholine. Using % predicted value may reduce bias in bronchial challenge testing, whilst maintaining discriminatory capability for hyper-reactivity. Figure 1. Grey bars – fall in % predicted that equated to a 20% fall from baseline FEV 1 . Grey lines - actual fall in % predicted at consecutive methacholine doses.

respiratory system